These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 12365406)
1. WHO and UNAIDS continue to support use of nevirapine for prevention of mother-to-child HIV transmission. J Adv Nurs; 2002 Sep; 39(6):519. PubMed ID: 12365406 [No Abstract] [Full Text] [Related]
2. The controversies of nevirapine for preventing mother-to-child HIV transmission. Smith DM AIDS; 2006 Jan; 20(2):281-3. PubMed ID: 16511423 [No Abstract] [Full Text] [Related]
3. This is no time to stop use of nevarapine to prevent mother-to-child transmission of HIV. Oleske JM AIDS; 2006 Apr; 20(7):1059-60. PubMed ID: 16603859 [No Abstract] [Full Text] [Related]
5. Preventing mother-to-infant transmission of HIV in the developing world. Laurence J AIDS Read; 1999 Oct; 9(7):448-9, 496. PubMed ID: 12737134 [No Abstract] [Full Text] [Related]
6. Two drugs reduce transmission. AIDS Patient Care STDS; 2002 Sep; 16(9):462. PubMed ID: 12412582 [No Abstract] [Full Text] [Related]
7. HIV transmission. Allegations raise fears of backlash against AIDS prevention strategy. Cohen J Science; 2004 Dec; 306(5705):2168-9. PubMed ID: 15618490 [No Abstract] [Full Text] [Related]
8. Single-dose nevirapine to prevent mother-to-child transmission of HIV type 1: balancing the benefits and risks. Mellors JW; Chow JY Clin Infect Dis; 2009 Feb; 48(4):473-5. PubMed ID: 19133800 [No Abstract] [Full Text] [Related]
9. Evidence behind the WHO guidelines: hospital care for children: what antiretroviral agents and regimens are effective in the prevention of mother-to-child transmission of HIV? Nightingale S; Dabis F J Trop Pediatr; 2006 Aug; 52(4):235-8. PubMed ID: 16877674 [No Abstract] [Full Text] [Related]
10. [Encouraging study results. HIV from birth on--virostatic drugs can decrease the risk]. MMW Fortschr Med; 1999 Aug; 141(34):61. PubMed ID: 10726137 [No Abstract] [Full Text] [Related]
12. Effectiveness of the first district-wide programme for the prevention of mother-to-child transmission of HIV in South Africa. Coetzee D; Hilderbrand K; Boulle A; Draper B; Abdullah F; Goemaere E Bull World Health Organ; 2005 Jul; 83(7):489-94. PubMed ID: 16175822 [TBL] [Abstract][Full Text] [Related]
13. Zidovudine with nevirapine for the prevention of HIV mother-to-child transmission reduces nevirapine resistance in mothers from the Western Cape, South Africa. van Zyl GU; Claassen M; Engelbrecht S; Laten JD; Cotton MF; Theron GB; Preiser W J Med Virol; 2008 Jun; 80(6):942-6. PubMed ID: 18428139 [TBL] [Abstract][Full Text] [Related]
14. Extra drugs and slower weaning lowers HIV risk for newborns. Hughes V Nat Med; 2008 Jul; 14(7):698. PubMed ID: 18607354 [No Abstract] [Full Text] [Related]
16. A randomized, double-blind, placebo-controlled trial of combined nevirapine and zidovudine compared with nevirapine alone in the prevention of perinatal transmission of HIV in Zimbabwe. Thistle P; Spitzer RF; Glazier RH; Pilon R; Arbess G; Simor A; Boyle E; Chitsike I; Chipato T; Gottesman M; Silverman M Clin Infect Dis; 2007 Jan; 44(1):111-9. PubMed ID: 17143826 [TBL] [Abstract][Full Text] [Related]
17. Reduction of materno-fetal transmission of HIV by improved delivery techniques combined with nevirapine treatment in women attending two family planning clinics in Yaounde, Cameroon. Mbu RE; Mbopi-Keou FX; Alemnji G; Nkengasong JN; Meli C; Eteki N; Nana PN; Ako SN; Tonye RN; Leke RJ Int J STD AIDS; 2004 Dec; 15(12):848-9. PubMed ID: 15601503 [No Abstract] [Full Text] [Related]